Stephens Inc. AR Reduces Stake in Guardian Pharmacy Services, Inc. (NYSE:GRDN)

Stephens Inc. AR lessened its holdings in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDNFree Report) by 7.1% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 10,450 shares of the company’s stock after selling 800 shares during the period. Stephens Inc. AR’s holdings in Guardian Pharmacy Services were worth $212,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in GRDN. Calamos Advisors LLC raised its holdings in Guardian Pharmacy Services by 124.7% during the fourth quarter. Calamos Advisors LLC now owns 24,725 shares of the company’s stock worth $501,000 after purchasing an additional 13,720 shares in the last quarter. R Squared Ltd purchased a new position in shares of Guardian Pharmacy Services in the 4th quarter valued at $30,000. Investment Research & Advisory Group Inc. purchased a new stake in Guardian Pharmacy Services in the fourth quarter valued at $34,000. Franklin Resources Inc. purchased a new stake in Guardian Pharmacy Services in the third quarter valued at $8,575,000. Finally, Virtu Financial LLC purchased a new position in shares of Guardian Pharmacy Services during the third quarter worth about $279,000.

Analysts Set New Price Targets

GRDN has been the subject of several research reports. Truist Financial boosted their target price on Guardian Pharmacy Services from $22.00 to $24.00 and gave the company a “buy” rating in a report on Friday, November 15th. Raymond James began coverage on Guardian Pharmacy Services in a research note on Monday, October 21st. They issued an “outperform” rating and a $21.00 price objective for the company. Finally, Stephens initiated coverage on shares of Guardian Pharmacy Services in a research report on Tuesday, October 22nd. They set an “overweight” rating and a $21.00 target price on the stock.

Check Out Our Latest Research Report on GRDN

Guardian Pharmacy Services Stock Performance

NYSE GRDN opened at $19.77 on Monday. Guardian Pharmacy Services, Inc. has a 52-week low of $14.16 and a 52-week high of $25.74. The business’s 50-day moving average is $21.50.

Insider Buying and Selling at Guardian Pharmacy Services

In related news, Director Steven D. Cosler bought 7,000 shares of the company’s stock in a transaction dated Tuesday, November 19th. The shares were acquired at an average price of $21.22 per share, with a total value of $148,540.00. Following the completion of the acquisition, the director now owns 17,713 shares in the company, valued at approximately $375,869.86. This trade represents a 65.34 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

About Guardian Pharmacy Services

(Free Report)

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.

Featured Stories

Want to see what other hedge funds are holding GRDN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Guardian Pharmacy Services, Inc. (NYSE:GRDNFree Report).

Institutional Ownership by Quarter for Guardian Pharmacy Services (NYSE:GRDN)

Receive News & Ratings for Guardian Pharmacy Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardian Pharmacy Services and related companies with MarketBeat.com's FREE daily email newsletter.